https://iraqhealthcarewire.com/article/907954581-kfsh-ampl-a-la-medicina-gen-mica-desde-la-investigaci-n-hasta-la-toma-de-decisiones-cl-nicas Iraq Healthcare Wire en PressRelease 2026-04-25T02:27:10+00:00 KFSH amplía la medicina genómica desde la investigación hasta la toma de decisiones clínicas https://ml.globenewswire.com/media/9f73a943-28c0-4ee7-a796-2407051abbe7/small/logo-kfshrc-png.png https://iraqhealthcarewire.com/article/907954626-kfsh-expande-a-medicina-gen-mica-da-pesquisa-para-a-tomada-de-decis-o-cl-nica Iraq Healthcare Wire en PressRelease 2026-04-25T02:27:10+00:00 KFSH Expande a Medicina Genômica da Pesquisa para a Tomada de Decisão Clínica https://ml.globenewswire.com/media/9f73a943-28c0-4ee7-a796-2407051abbe7/small/logo-kfshrc-png.png https://iraqhealthcarewire.com/article/907937662-alpha-labs-male-enhancement-gummies-claims-evaluated-the-alphalabs-ed-gummy-for-men-under-investigation Iraq Healthcare Wire en PressRelease 2026-04-25T00:37:11+00:00 Alpha Labs Male Enhancement Gummies Claims Evaluated: The AlphaLabs ED Gummy for Men Under Investigation https://zingfast.com/wp-content/uploads/2026/04/Alpha-Labs-Male-Enhancement-Gummies.jpg https://iraqhealthcarewire.com/article/907891379-performance-lab-under-investigation-premium-grade-nutritional-supplements-with-research-backed-ingredients-that-work Iraq Healthcare Wire en PressRelease 2026-04-24T21:46:40+00:00 Performance Lab Under Investigation: Premium-Grade Nutritional Supplements with Research-Backed Ingredients That Work https://zingfast.com/wp-content/uploads/2026/04/Performance-Lab-Supplements.jpg https://iraqhealthcarewire.com/article/907862916-ultragenyx-reports-inducement-grant-under-nasdaq-listing-rule-5635-c-4 Iraq Healthcare Wire en PressRelease 2026-04-24T20:30:00+00:00 Ultragenyx Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4) https://ml.globenewswire.com/media/121a9bda-7a64-41f8-85e8-1693a2dfa977/small/ultragenyx-cmyk-png.png https://iraqhealthcarewire.com/article/907863572-park-dental-partners-announces-dates-for-first-quarter-2026-earnings-release-and-conference-call Iraq Healthcare Wire en PressRelease 2026-04-24T20:16:00+00:00 Park Dental Partners Announces Dates for First Quarter 2026 Earnings Release and Conference Call https://ml.globenewswire.com/media/48fd5730-f848-4991-96db-3d4db3274d34/small/pdp-rgb-jpg.jpg https://iraqhealthcarewire.com/article/907863254-crescent-biopharma-announces-grants-of-inducement-awards Iraq Healthcare Wire en PressRelease 2026-04-24T20:15:00+00:00 Crescent Biopharma Announces Grants of Inducement Awards https://ml.globenewswire.com/media/57dabf2a-90a3-4786-9c39-d1e71cc7707f/small/crescent-biopharma-logo-color-png.png https://iraqhealthcarewire.com/article/907862990-aeon-biopharma-sets-annual-shareholder-meeting Iraq Healthcare Wire en PressRelease 2026-04-24T20:05:00+00:00 AEON Biopharma Sets Annual Shareholder Meeting https://ml.globenewswire.com/media/c49be6f2-5e65-4a6d-9aef-e6b695554fb6/small/aeon-logo-png.png https://iraqhealthcarewire.com/article/907863974-intellia-therapeutics-to-report-topline-data-from-global-phase-3-haelo-clinical-trial-of-lonvoguran-ziclumeran-in-hereditary-angioedema-on-april-27 Iraq Healthcare Wire en PressRelease 2026-04-24T20:05:00+00:00 Intellia Therapeutics to Report Topline Data from Global Phase 3 HAELO Clinical Trial of Lonvoguran Ziclumeran in Hereditary Angioedema on April 27, 2026 https://ml.globenewswire.com/media/9b6b17bb-c8a4-4009-b5f8-8cadb4d2296a/small/intellia-jpg.jpg https://iraqhealthcarewire.com/article/907863052-compass-therapeutics-to-announce-topline-secondary-endpoints-from-the-phase-2-3-companion-002-study-of-tovecimig-in-patients-with-biliary-tract-cancer Iraq Healthcare Wire en PressRelease 2026-04-24T20:00:00+00:00 Compass Therapeutics to Announce Topline Secondary Endpoints from the Phase 2/3 COMPANION-002 Study of Tovecimig in Patients with Biliary Tract Cancer https://ml.globenewswire.com/media/b8470129-5d30-4368-8074-d77404b65be8/small/compass-logo-rgb-outlines-png.png https://iraqhealthcarewire.com/article/907864345-fda-accelerates-action-on-treatments-for-serious-mental-illness-following-executive-order Iraq Healthcare Wire en PressRelease 2026-04-24T19:58:44+00:00 FDA Accelerates Action on Treatments for Serious Mental Illness Following Executive Order https://ml.globenewswire.com/media/MWQ3ODlmMmYtNjY3OC00YThmLTljNGEtZGM4Y2I3NDcxMDMzLTUwMDE1NDE1NC0yMDI2LTA0LTI0LWVu/tiny/FDA.png https://iraqhealthcarewire.com/article/907834419-delaware-chancery-court-rules-in-favor-of-anaptys-by-dismissing-tesaro-s-anticipatory-breach-claim Iraq Healthcare Wire en PressRelease 2026-04-24T19:40:00+00:00 Delaware Chancery Court Rules in Favor of Anaptys by Dismissing Tesaro’s Anticipatory Breach Claim https://ml.globenewswire.com/media/eb223f66-e7e0-4e0a-94e7-a3f7a06b13ab/small/anaptys-logo-png.png https://iraqhealthcarewire.com/article/907833308-forlife-and-oakmed-ltd-to-become-unora-gmbh-and-unora-healthcare-ltd-effective-may-1-2026 Iraq Healthcare Wire en PressRelease 2026-04-24T19:00:00+00:00 ForLife and Oakmed Ltd. to Become Unora GmbH and Unora Healthcare Ltd Effective May 1, 2026 https://ml-eu.globenewswire.com/media/ZTBmOWRlZTUtZjE4MC00NDBlLWJiZDMtMzkzNWU2OTFhYWU2LTEzMjI5MzAtMjAyNi0wNC0yNC1lbg==/tiny/ForLife.png https://iraqhealthcarewire.com/article/907833851-biotech-startup-plopii-files-us-patent-on-the-next-generation-headache-pill Iraq Healthcare Wire en PressRelease 2026-04-24T18:32:58+00:00 Biotech startup Plopii Files US Patent on the Next-Generation Headache Pill https://ml.globenewswire.com/media/739b4d63-30b2-44c2-ab95-2446ee5dc3bf/medium/plopii-headache-pill.jpg https://iraqhealthcarewire.com/article/907833353-press-release-sanofi-successfully-prices-2-3-billion-of-bond-issue Iraq Healthcare Wire en PressRelease 2026-04-24T18:30:00+00:00 Press Release: Sanofi successfully prices 2.3 billion of bond issue https://ml-eu.globenewswire.com/media/06da731a-67a1-4258-939f-6ef0531ee3bf/small/sanofi-new-logo-jpg.jpg https://iraqhealthcarewire.com/article/907833358-communiqu-de-presse-sanofi-place-2-3-milliard-d-euros-d-emprunts-obligataires Iraq Healthcare Wire en PressRelease 2026-04-24T18:30:00+00:00 Communiqué de presse : Sanofi place 2,3 milliard d’euros d’emprunts obligataires https://ml-eu.globenewswire.com/media/06da731a-67a1-4258-939f-6ef0531ee3bf/small/sanofi-new-logo-jpg.jpg https://iraqhealthcarewire.com/article/907800388-rta-outdoor-living-launches-health-haven-youtube-special-on-backyard-design-and-health Iraq Healthcare Wire en PressRelease 2026-04-24T17:10:00+00:00 RTA Outdoor Living Launches 'Health Haven' YouTube Special on Backyard Design and Health https://pressranger.s3.us-west-1.amazonaws.com/3235413/RTA-Health-Haven.jpg https://iraqhealthcarewire.com/article/907798892-metabo-drops-2026-launch-tasteless-drop-effective-weight-loss-turns-any-coffee-into-boosted-metabolism-explained-fat-burning-supplement-metabodrops Iraq Healthcare Wire en PressRelease 2026-04-24T16:05:46+00:00 Metabo Drops 2026 | Launch "Tasteless Drop Effective Weight Loss Turns Any Coffee Into Boosted Metabolism Explained Fat Burning Supplement MetaboDrops https://ml-eu.globenewswire.com/Resource/Download/3bf2deb4-4049-4eb5-94c2-48515480ddd1/untitled-design.jpg https://iraqhealthcarewire.com/article/907764139-kfsh-scales-genomic-medicine-from-research-to-clinical-decision-making Iraq Healthcare Wire en PressRelease 2026-04-24T15:23:15+00:00 KFSH Scales Genomic Medicine from Research to Clinical Decision-Making https://ml.globenewswire.com/media/9f73a943-28c0-4ee7-a796-2407051abbe7/small/logo-kfshrc-png.png https://iraqhealthcarewire.com/article/907759706-indivior-presents-new-real-world-data-at-asam-2026-annual-conference-supporting-remission-as-a-treatment-outcome-and-reinforcing-the-clinical Iraq Healthcare Wire en PressRelease 2026-04-24T15:00:00+00:00 Indivior Presents New Real-World Data at ASAM 2026 Annual Conference, Supporting Remission as a Treatment Outcome and Reinforcing the Clinical Benefits of Monthly Injectable Buprenorphine for Opioid Use Disorder https://ml-eu.globenewswire.com/media/42de3285-90ea-4020-a3ad-25f71026b41a/small/indivior-logo-jpg.jpg https://iraqhealthcarewire.com/article/907763997-dna-day-2026-genelife-advances-geneai-forecast-with-15-predictive-models-and-enhanced-lifestyle-integration Iraq Healthcare Wire en PressRelease 2026-04-24T14:43:07+00:00 DNA DAY™ 2026: GeneLife Advances GeneAI Forecast with 15 Predictive Models and Enhanced Lifestyle Integration https://ml.globenewswire.com/media/57b381e4-7649-49a9-bf54-e247c5a8cf1f/small/adam-innovations-horizontal-png.png https://iraqhealthcarewire.com/article/907759597-medicana-health-group-launches-hpv-vaccination-and-cervical-cancer-awareness-campaign-advancing-prevention-through-regular-check-ups Iraq Healthcare Wire en PressRelease 2026-04-24T14:37:44+00:00 Medicana Health Group Launches HPV Vaccination and Cervical Cancer Awareness Campaign, Advancing Prevention Through Regular Check-Ups https://ml-eu.globenewswire.com/media/06c0ab7c-b420-4596-bede-a390553593aa/medium/medicana-atakoy-hospital-in-istanbul.png https://iraqhealthcarewire.com/article/907761369-a-d-a-m-innovations-unveils-genelock-the-world-s-first-genetic-data-protection-platform Iraq Healthcare Wire en PressRelease 2026-04-24T14:19:03+00:00 A.D.A.M. Innovations Unveils GeneLock™: The World’s First Genetic Data Protection Platform https://ml.globenewswire.com/media/57b381e4-7649-49a9-bf54-e247c5a8cf1f/small/adam-innovations-horizontal-png.png https://iraqhealthcarewire.com/article/907759565-the-genius-song-the-brain-song-official-2026-7-second-brain-trick-genius-brainwave-music-to-improve-focus-and-memory-by-genius-wave Iraq Healthcare Wire en PressRelease 2026-04-24T14:17:10+00:00 The Genius Song & The Brain Song Official 2026: 7-Second Brain Trick’  Genius Brainwave Music to Improve Focus and memory By Genius wave? https://ml-eu.globenewswire.com/Resource/Download/e3c386da-82aa-41df-a99a-5d137fea950c/248c38ea-054b-4243-9dd0-8047be50f80a.png https://iraqhealthcarewire.com/article/907761517-actg-launches-landmark-study-evaluating-treatments-for-depressive-disorders-with-or-without-mild-neurocognitive-disorder-among-people-living-with-hiv Iraq Healthcare Wire en PressRelease 2026-04-24T14:05:48+00:00 ACTG Launches Landmark Study Evaluating Treatments for Depressive Disorders with or without Mild Neurocognitive Disorder among People Living with HIV https://ml.globenewswire.com/media/1e94313a-1d33-49e8-bd5e-fd0c911661c9/small/image1-png.png https://iraqhealthcarewire.com/article/907761456-new-lung-preservation-studies-showcase-key-insights-of-optimizing-temperature-and-airway-pressure-control Iraq Healthcare Wire en PressRelease 2026-04-24T13:43:35+00:00 New Lung Preservation Studies Showcase Key Insights of Optimizing Temperature and Airway Pressure Control https://ml.globenewswire.com/media/5b56fec1-dc1d-480e-8a0b-aa723d7e7cf9/small/paragonix-getinge-bluecenter-png.png https://iraqhealthcarewire.com/article/907760154-acentra-health-chief-ai-officer-sean-harrison-named-to-nvtc-ai50 Iraq Healthcare Wire en PressRelease 2026-04-24T13:33:00+00:00 Acentra Health Chief AI Officer Sean Harrison Named to NVTC AI50 https://ml.globenewswire.com/media/d6577e18-c840-416c-9ce5-fce049b2b0b8/medium/acentra-health-chief-ai-officer-sean-harrison-2026-nvtc-ai50.png https://iraqhealthcarewire.com/article/907736721-alvotech-to-report-financial-results-for-the-first-quarter-of-2026 Iraq Healthcare Wire en PressRelease 2026-04-24T12:30:00+00:00 Alvotech to Report Financial Results for the First Quarter of 2026 https://ml-eu.globenewswire.com/media/17a8091d-68a6-47c1-968e-fcced99f1d44/small/alvotech-logo-jpg.jpg https://iraqhealthcarewire.com/article/907737194-jushi-holdings-inc-announces-proposed-continuance-from-british-columbia-to-nevada Iraq Healthcare Wire en PressRelease 2026-04-24T12:30:00+00:00 Jushi Holdings Inc. Announces Proposed Continuance from British Columbia to Nevada https://ml.globenewswire.com/media/e65f15fd-322c-4847-83c5-ceafe27f97d5/small/jushi-png.png https://iraqhealthcarewire.com/article/907741044-gain-therapeutics-announces-oral-presentation-at-3rd-international-gba1-meeting-2026 Iraq Healthcare Wire en PressRelease 2026-04-24T12:30:00+00:00 Gain Therapeutics Announces Oral Presentation at 3rd International GBA1 Meeting 2026 https://ml.globenewswire.com/media/b08fa984-9f20-4aa1-a174-b9f6165d50fa/small/gainlogo-png.png https://iraqhealthcarewire.com/article/907736804-aligos-therapeutics-announces-inducement-grants-under-nasdaq-listing-rule-5635-c-4 Iraq Healthcare Wire en PressRelease 2026-04-24T12:00:00+00:00 Aligos Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) https://ml.globenewswire.com/media/03ffbe89-c47f-4f83-b51f-f13a572e2cd1/small/aligos-png.png https://iraqhealthcarewire.com/article/907736818-media-advisory-ontario-health-coalition-large-cross-province-protests-this-saturday-ford-gov-t-pushing-our-hospitals-into-deficit-cuts-while-paying Iraq Healthcare Wire en PressRelease 2026-04-24T12:00:00+00:00 Media Advisory-Ontario Health Coalition/Large cross-province protests this Saturday: Ford gov’t pushing our hospitals into deficit & cuts while paying more to privatize their services https://ml.globenewswire.com/media/fdd00e9f-f066-4244-85e8-d12e6d1b760c/small/screen-shot-2023-09-14-at-1-49-15-pm-png.png https://iraqhealthcarewire.com/article/907739284-oncotelic-therapeutics-provides-corporate-update-on-partnership-strategy Iraq Healthcare Wire en PressRelease 2026-04-24T12:00:00+00:00 Oncotelic Therapeutics Provides Corporate Update on Partnership Strategy https://ml.globenewswire.com/media/b57f4b15-bff1-4da1-872b-ed2b51984ad9/small/logo-png.png https://iraqhealthcarewire.com/article/907739927-humacyte-expands-commercial-and-business-development-opportunities-through-realignment-of-ex-u-s-rights-to-symvess Iraq Healthcare Wire en PressRelease 2026-04-24T12:00:00+00:00 Humacyte Expands Commercial and Business Development Opportunities Through Realignment of Ex-U.S. Rights to Symvess® https://ml.globenewswire.com/media/e81aff26-ead8-404d-aebb-159b45c3e7b1/small/huma-logo-png.png https://iraqhealthcarewire.com/article/907740707-kyowa-kirin-and-kura-oncology-initiate-japanese-phase-2-registration-directed-trial-of-ziftomenib-in-r-r-npm1-m-aml Iraq Healthcare Wire en PressRelease 2026-04-24T12:00:00+00:00 Kyowa Kirin and Kura Oncology Initiate Japanese Phase 2 Registration-Directed Trial of Ziftomenib in R/R NPM1-m AML https://ml.globenewswire.com/media/OTAwNGNlMDQtMzYzYy00OGU0LWFmMDEtNGJlZjYxMmFkYTBiLTUwMDE1MDY0OC0yMDI2LTA0LTI0LWVu/tiny/Kyowa-Kirin.png https://iraqhealthcarewire.com/article/907739939-30-years-of-smiles-st-augustine-s-premier-cosmetic-dentist-marks-a-career-built-on-artistry Iraq Healthcare Wire en PressRelease 2026-04-24T11:15:00+00:00 30 Years of Smiles: St. Augustine’s Premier Cosmetic Dentist Marks a Career Built on Artistry https://ml.globenewswire.com/media/4f184569-4d95-4d3d-931d-5e5f91a99b7c/medium/dr-atosa-khan-and-her-team-in-st-augustine-dental-office.jpg https://iraqhealthcarewire.com/article/907739950-free-carotenoid-eye-screenings-offered-to-seacoast-residents-near-portsmouth-nh Iraq Healthcare Wire en PressRelease 2026-04-24T11:15:00+00:00 Free Carotenoid Eye Screenings Offered to Seacoast Residents Near Portsmouth, NH https://ml.globenewswire.com/media/d978536b-c1ca-4073-80a0-49c16a604507/medium/modern-vision-center-near-portsmouth-nh-eye-exams-and-optica.jpg https://iraqhealthcarewire.com/article/907740309-dogecoin-cash-inc-highlights-telehealth-platform-strategy-following-federal-actions-relating-to-marijuana-reclassification Iraq Healthcare Wire en PressRelease 2026-04-24T11:15:00+00:00 Dogecoin Cash, Inc. Highlights Telehealth Platform Strategy Following Federal Actions Relating to Marijuana Reclassification https://ml.globenewswire.com/media/59f902b1-29a7-4b48-a71a-96f3cf2ed92e/small/dc-cash-header-new-jpg.jpg https://iraqhealthcarewire.com/article/907737483-treace-to-report-first-quarter-2026-financial-results-on-may-8-2026 Iraq Healthcare Wire en PressRelease 2026-04-24T11:05:00+00:00 Treace to Report First Quarter 2026 Financial Results on May 8, 2026 https://ml.globenewswire.com/media/e6af4ccc-19b1-4fe0-948f-436f2b9d2ea5/small/treace-color-jpg.jpg https://iraqhealthcarewire.com/article/907739736-senseonics-announces-european-launch-of-eversense-365-the-world-s-first-and-only-one-year-cgm-system Iraq Healthcare Wire en PressRelease 2026-04-24T11:00:00+00:00 Senseonics Announces European Launch of Eversense® 365, The World’s First and Only One Year CGM System https://ml.globenewswire.com/media/7f64f449-dd5d-4bd1-9504-82adb3846669/small/logo-png.png https://iraqhealthcarewire.com/article/907741286-syndax-to-announce-first-quarter-2026-financial-results-and-host-conference-call-and-webcast-on-april-30-2026 Iraq Healthcare Wire en PressRelease 2026-04-24T11:00:00+00:00 Syndax to Announce First Quarter 2026 Financial Results and Host Conference Call and Webcast on April 30, 2026 https://ml.globenewswire.com/media/399a65b5-bd4f-4ba5-980b-f4d0af9ae6a0/small/syndax-logo-jpg.jpg https://iraqhealthcarewire.com/article/907740603-ani-pharmaceuticals-to-discuss-first-quarter-2026-financial-results-on-may-8-2026-at-8-00-a-m-et Iraq Healthcare Wire en PressRelease 2026-04-24T10:50:00+00:00 ANI Pharmaceuticals to Discuss First Quarter 2026 Financial Results on May 8, 2026, at 8:00 a.m. ET https://ml.globenewswire.com/media/24d1d851-9075-4d6e-b22c-0c23a5ef0b36/small/ani-logo-png.png https://iraqhealthcarewire.com/article/907715752-press-release-sanofi-s-cenrifki-tolebrutinib-recommended-for-eu-approval-by-the-chmp-to-treat-secondary-progressive-multiple-sclerosis-without Iraq Healthcare Wire en PressRelease 2026-04-24T10:09:31+00:00 Press Release: Sanofi’s Cenrifki (tolebrutinib) recommended for EU approval by the CHMP to treat secondary progressive multiple sclerosis without relapses https://ml-eu.globenewswire.com/media/06da731a-67a1-4258-939f-6ef0531ee3bf/small/sanofi-new-logo-jpg.jpg https://iraqhealthcarewire.com/article/907715819-communiqu-de-presse-cenrifki-de-sanofi-tolebrutinib-recommand-par-le-comit-des-m-dicaments-usage-humain-cmuh-pour-tre-approuv-par-l-ue Iraq Healthcare Wire en PressRelease 2026-04-24T10:09:31+00:00 Communiqué de presse : Cenrifki de Sanofi (tolebrutinib) recommandé par le Comité des médicaments à usage humain (CMUH) pour être approuvé par l’UE pour le traitement de la sclérose en plaques secondairement progressive sans poussées https://ml-eu.globenewswire.com/media/06da731a-67a1-4258-939f-6ef0531ee3bf/small/sanofi-new-logo-jpg.jpg https://iraqhealthcarewire.com/article/907694179-amphista-therapeutics-announces-presentation-of-new-preclinical-data-from-its-smarca2-and-tead-targeted-glue-degrader-programs-at-aacr-2026-and Iraq Healthcare Wire en PressRelease 2026-04-24T08:00:27+00:00 Amphista Therapeutics announces presentation of new preclinical data from its SMARCA2 and TEAD Targeted Glue™ degrader programs at AACR 2026, and publication of the first data on its TEAD program https://ml-eu.globenewswire.com/media/d3d2174f-591e-4e13-9a89-363dcbfe5c68/small/amphista-horiz-logo-rgb-1500px-png.png https://iraqhealthcarewire.com/article/907693813-levicept-to-present-data-from-phase-ii-study-of-levi-04-at-oarsi-2026-world-congress-on-osteoarthritis Iraq Healthcare Wire en PressRelease 2026-04-24T08:00:00+00:00 Levicept to Present Data from Phase II study of LEVI-04 at OARSI 2026 World Congress on Osteoarthritis https://ml-eu.globenewswire.com/media/44086146-ae7c-40ad-9e1d-326ca3bfbf7e/small/levicept-logo-png.png https://iraqhealthcarewire.com/article/907694096-geneva-college-of-longevity-science-launches-the-world-s-first-phd-in-longevity-sciences Iraq Healthcare Wire en PressRelease 2026-04-24T07:40:52+00:00 Geneva College of Longevity Science Launches the World’s First PhD in Longevity Sciences https://ml-eu.globenewswire.com/media/OWQzNGMzY2EtZDhmMi00NGJiLTgzY2MtMmNkZjAwZTJkZjMyLTEzMTkzMzAtMjAyNi0wNC0yNC1lbg==/tiny/GCLS.png https://iraqhealthcarewire.com/article/907672922-clinuvel-receives-final-ema-scientific-advice-for-pivotal-phase-iii-vitiligo-study Iraq Healthcare Wire en PressRelease 2026-04-24T05:47:18+00:00 CLINUVEL receives final EMA scientific advice for pivotal Phase III vitiligo study https://ml.globenewswire.com/media/e44ebc14-276f-4e7b-9f19-76924f349ecf/small/navy-cuv-logo-rgb-1200x628px-png.png https://iraqhealthcarewire.com/article/907671711-novartis-malaria-treatment-coartem-baby-receives-who-prequalification-paving-way-for-greater-access-for-newborns-and-young-infants Iraq Healthcare Wire en PressRelease 2026-04-24T05:15:00+00:00 Novartis malaria treatment Coartem® Baby receives WHO prequalification, paving way for greater access for newborns and young infants https://ml-eu.globenewswire.com/media/f0161a05-9638-4da5-a4af-f9cdb28f0304/small/logo-warm-black-rgb-jpg.jpg https://iraqhealthcarewire.com/article/907651064-fda-approves-first-ever-gene-therapy-for-treatment-of-genetic-hearing-loss-under-national-priority-voucher-program Iraq Healthcare Wire en PressRelease 2026-04-24T02:04:21+00:00 FDA Approves First-Ever Gene Therapy for Treatment of Genetic Hearing Loss Under National Priority Voucher Program https://ml.globenewswire.com/media/ZDc3Yjg1MzAtMzMxYi00M2Q4LTg1ZDYtYWM5NmVjN2E5OGIxLTUwMDE1NDE1NC0yMDI2LTA0LTI0LWVu/tiny/FDA.png https://iraqhealthcarewire.com/article/907606651-agomab-reports-full-year-2025-financial-results-and-confirms-2026-outlook Iraq Healthcare Wire en PressRelease 2026-04-23T22:14:17+00:00 Agomab Reports Full Year 2025 Financial Results and Confirms 2026 Outlook https://ml-eu.globenewswire.com/media/7f797bcb-5d5d-4fb6-a862-b5c861b83e54/small/agomab-logo-png.png https://iraqhealthcarewire.com/article/907608934-kane-biotech-announces-fourth-quarter-and-full-year-2025-financial-results Iraq Healthcare Wire en PressRelease 2026-04-23T22:00:00+00:00 Kane Biotech Announces Fourth Quarter and Full Year 2025 Financial Results https://ml.globenewswire.com/media/a2ad1d52-1d5a-425c-93de-45cc52c3784b/small/kane-logo-cropped-transbg-png.png https://iraqhealthcarewire.com/article/907609136-denta-biome-under-investigation-adem-naturals-chewable-dental-tablets-for-oral-health-care-support Iraq Healthcare Wire en PressRelease 2026-04-23T21:55:49+00:00 Denta Biome Under Investigation: Adem Naturals Chewable Dental Tablets for Oral Health Care Support https://zingfast.com/wp-content/uploads/2026/04/Denta-Biome-1.jpg https://iraqhealthcarewire.com/article/907608901-skinnyrx-glp-1-claims-evaluated-review-semaglutide-tirzepatide-weight-loss-medication-options-with-clinician-guided-care Iraq Healthcare Wire en PressRelease 2026-04-23T21:14:21+00:00 SkinnyRx GLP-1 Claims Evaluated: Review Semaglutide & Tirzepatide Weight Loss Medication Options with Clinician-Guided Care https://zingfast.com/wp-content/uploads/2026/04/SkinnyRx-GLP-1.jpg https://iraqhealthcarewire.com/article/907608533-vaxart-appoints-james-breitmeyer-m-d-ph-d-to-board-of-directors Iraq Healthcare Wire en PressRelease 2026-04-23T20:30:00+00:00 Vaxart Appoints James Breitmeyer, M.D., Ph.D., to Board of Directors https://ml.globenewswire.com/media/aedaf06c-26f8-482c-ac72-39774eab2c35/small/vxrt-logo-jpg.png https://iraqhealthcarewire.com/article/907606817-chemed-reports-first-quarter-2026-results Iraq Healthcare Wire en PressRelease 2026-04-23T20:15:00+00:00 Chemed Reports First-Quarter 2026 Results https://ml.globenewswire.com/media/1ab951c0-8d76-40e0-bc65-ebeaa1731e66/small/chemed-corp-logo-600x400-jpg.jpg https://iraqhealthcarewire.com/article/907587196-avita-medical-to-announce-first-quarter-2026-financial-results Iraq Healthcare Wire en PressRelease 2026-04-23T20:10:00+00:00 AVITA Medical to Announce First Quarter 2026 Financial Results https://ml.globenewswire.com/media/53ad8139-952a-4470-9ede-2f3bf0521f16/small/avita-png.png https://iraqhealthcarewire.com/article/907586585-dyne-therapeutics-reports-inducement-grants-under-nasdaq-listing-rule-5635-c-4 Iraq Healthcare Wire en PressRelease 2026-04-23T20:05:00+00:00 Dyne Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) https://ml.globenewswire.com/media/2aa597a4-9b5c-4f0c-9ada-c5e06fa7d4de/small/dynelogo-r-final-full-color-rgb-jpg.jpg https://iraqhealthcarewire.com/article/907587189-outlook-therapeutics-announces-closing-of-5-0-million-registered-direct-offering Iraq Healthcare Wire en PressRelease 2026-04-23T20:05:00+00:00 Outlook Therapeutics Announces Closing of $5.0 Million Registered Direct Offering https://ml.globenewswire.com/media/cbff3302-f8d2-466a-beff-8c33252f9c70/small/otlk-png.png https://iraqhealthcarewire.com/article/907587246-trevi-therapeutics-to-participate-in-upcoming-may-events Iraq Healthcare Wire en PressRelease 2026-04-23T20:05:00+00:00 Trevi Therapeutics to Participate in Upcoming May Events https://ml.globenewswire.com/media/b97e9d57-6e8e-4570-87da-ea38c273f7c8/small/trevi-logo-jpg.jpg https://iraqhealthcarewire.com/article/907587485-heartflow-to-report-first-quarter-2026-financial-results-on-may-14-2026 Iraq Healthcare Wire en PressRelease 2026-04-23T20:05:00+00:00 Heartflow to Report First Quarter 2026 Financial Results on May 14, 2026 https://ml.globenewswire.com/media/c6be111e-2f8e-4ac8-8fa8-310dbcbd6e15/small/25-1113-cmyk-hf-logo-positive-png.png https://iraqhealthcarewire.com/article/907587550-leonabio-to-host-virtual-key-opinion-leader-event-highlighting-potential-of-lasofoxifene-in-treatment-resistant-er-her2-esr1-mutated-metastatic Iraq Healthcare Wire en PressRelease 2026-04-23T20:05:00+00:00 LeonaBio to Host Virtual Key Opinion Leader Event Highlighting Potential of Lasofoxifene in Treatment-Resistant ER+/HER2-, ESR1-Mutated Metastatic Breast Cancer https://ml.globenewswire.com/media/84ac024a-139b-463f-a43f-ed787a66c0fd/small/image1-jpg.jpg https://iraqhealthcarewire.com/article/907587597-cytek-biosciences-to-report-first-quarter-2026-financial-results-on-may-7-2026 Iraq Healthcare Wire en PressRelease 2026-04-23T20:05:00+00:00 Cytek Biosciences to Report First Quarter 2026 Financial Results on May 7, 2026 https://ml.globenewswire.com/media/5a33b17c-e545-48d8-b797-832cf8e4372c/small/cytek-logo-color-jpg.jpg https://iraqhealthcarewire.com/article/907588857-itonic-holdings-ltd-granted-an-extension-of-additional-180-day-by-nasdaq-to-regain-compliance-with-minimum-bid-price-rule Iraq Healthcare Wire en PressRelease 2026-04-23T20:05:00+00:00 iTonic Holdings Ltd Granted An Extension of Additional 180-Day by Nasdaq to Regain Compliance with Minimum Bid Price Rule https://ml.globenewswire.com/media/7785d449-a9e0-4ea1-86eb-ff46d45db4db/small/phetonlogo-jpg.jpg https://iraqhealthcarewire.com/article/907586362-kiniksa-pharmaceuticals-to-report-first-quarter-2026-financial-results-on-april-28-2026 Iraq Healthcare Wire en PressRelease 2026-04-23T20:01:00+00:00 Kiniksa Pharmaceuticals to Report First Quarter 2026 Financial Results on April 28, 2026 https://ml-eu.globenewswire.com/media/84055882-69ed-48db-be7d-99cc55be5ff3/small/image1-jpg.jpg https://iraqhealthcarewire.com/article/907586974-weight-watchers-schedules-first-quarter-2026-earnings-conference-call Iraq Healthcare Wire en PressRelease 2026-04-23T20:01:00+00:00 Weight Watchers Schedules First Quarter 2026 Earnings Conference Call https://ml.globenewswire.com/media/f435b439-7f75-4d2f-a6cc-0e4e2ed811ea/small/weightwatchers-wordmark-boldblue-png.png https://iraqhealthcarewire.com/article/907587307-tectonic-therapeutic-appoints-jessica-chutter-to-board-of-directors Iraq Healthcare Wire en PressRelease 2026-04-23T20:01:00+00:00 Tectonic Therapeutic Appoints Jessica Chutter to Board of Directors https://ml.globenewswire.com/media/7c13d2a1-2971-4ab0-a4b5-608923316546/small/tectonic-logo-full-color-png.png https://iraqhealthcarewire.com/article/907590339-the-root-brands-earns-national-recognition-for-patent-driven-wellness-innovation-and-science-backed-consumer-products Iraq Healthcare Wire en PressRelease 2026-04-23T19:53:45+00:00 The ROOT Brands Earns National Recognition for Patent‑Driven Wellness Innovation and Science‑Backed Consumer Products https://ml.globenewswire.com/media/NTRkM2NjZTItMGM5Yy00OWVjLTk0M2MtM2Q1YWI1NzI0NWU4LTUwMDE1MDU0NC0yMDI2LTA0LTIzLWVu/tiny/The-ROOT-Brands.png https://iraqhealthcarewire.com/article/907589890-regeneron-announces-agreement-with-u-s-government-to-help-lower-drug-costs-for-american-patients-and-will-provide-innovative-new-gene-therapy-for Iraq Healthcare Wire en PressRelease 2026-04-23T19:46:16+00:00 Regeneron Announces Agreement with U.S. Government to Help Lower Drug Costs for American Patients and Will Provide Innovative New Gene Therapy for Free in the U.S. https://ml.globenewswire.com/media/add5ebc7-88c9-49dc-8834-abbb07c622d1/small/regeneron-logo-jpg.jpg https://iraqhealthcarewire.com/article/907589070-this-alcohol-awareness-month-oxford-treatment-center-raises-red-flag-citing-significant-rise-in-patients-seeking-help-for-alcohol-addiction Iraq Healthcare Wire en PressRelease 2026-04-23T19:45:00+00:00 This Alcohol Awareness Month, Oxford Treatment Center Raises Red Flag, Citing Significant Rise in Patients Seeking Help for Alcohol Addiction https://ml.globenewswire.com/media/0b3eec6b-83f7-4bfa-8d29-d07dbb759e65/small/oxford-logo-jpg.jpg https://iraqhealthcarewire.com/article/907589816-cook-county-health-recognizes-60th-anniversary-of-trauma-unit Iraq Healthcare Wire en PressRelease 2026-04-23T19:38:53+00:00 Cook County Health Recognizes 60th Anniversary of Trauma Unit https://ml.globenewswire.com/media/NDQ1YjhiYjctOTZhNS00YjAxLWI1ZGQtNjkzN2EzNzY5MmUyLTUwMDEyMzk3My0yMDI2LTA0LTIzLWVu/tiny/Cook-County-Health.png https://iraqhealthcarewire.com/article/907589540-hormify-launches-transparent-research-based-supplement-for-hormonal-balance-and-daily-wellness Iraq Healthcare Wire en PressRelease 2026-04-23T19:27:22+00:00 Hormify Launches Transparent, Research-Based Supplement for Hormonal Balance and Daily Wellness https://ml.globenewswire.com/media/e538c302-eeee-4287-9d09-5cc8e08f5b4c/small/555-jpg.jpg https://iraqhealthcarewire.com/article/907588094-ai-powered-nerve-monitoring-systems-poised-to-transform-surgical-safety-as-workforce-shortages-drive-remote-monitoring-adoption Iraq Healthcare Wire en PressRelease 2026-04-23T18:03:16+00:00 AI-Powered Nerve Monitoring Systems Poised to Transform Surgical Safety as Workforce Shortages Drive Remote Monitoring Adoption https://ml.globenewswire.com/media/d0c282b6-d496-45a8-a941-33fa5c3e824c/small/bcc-logo-1200-630-png.png https://iraqhealthcarewire.com/article/907587687-progyny-inc-announces-details-for-its-first-quarter-2026-results-report Iraq Healthcare Wire en PressRelease 2026-04-23T17:55:46+00:00 Progyny, Inc. Announces Details for Its First Quarter 2026 Results Report https://ml.globenewswire.com/media/1342dacd-99c3-4043-af8a-2fd5e9ea569f/small/progyny-203860-no-tag-png.png https://iraqhealthcarewire.com/article/907570099-grace-therapeutics-provides-regulatory-update-on-new-drug-application-for-gtx-104 Iraq Healthcare Wire en PressRelease 2026-04-23T17:13:24+00:00 Grace Therapeutics Provides Regulatory Update on New Drug Application for GTx-104 https://ml.globenewswire.com/media/c71c0a95-caed-4520-87a9-ac7fefef3f07/small/grce-logo-jpg.jpg https://iraqhealthcarewire.com/article/907570032-otarmeni-lunsotogene-parvec-cwha-approved-by-fda-as-first-and-only-gene-therapy-for-genetic-hearing-loss-regeneron-to-provide-otarmeni-for-free-in Iraq Healthcare Wire en PressRelease 2026-04-23T16:40:00+00:00 Otarmeni™ (lunsotogene parvec-cwha) Approved by FDA as First and Only Gene Therapy for Genetic Hearing Loss; Regeneron to Provide Otarmeni for Free in the U.S. https://ml.globenewswire.com/media/add5ebc7-88c9-49dc-8834-abbb07c622d1/small/regeneron-logo-jpg.jpg https://iraqhealthcarewire.com/article/907569967-pridcor-therapeutics-secures-global-antiviral-portfolio-establishing-leadership-in-treatment-of-long-covid-and-infection-associated-chronic-illnesses Iraq Healthcare Wire en PressRelease 2026-04-23T16:14:40+00:00 PridCor Therapeutics Secures Global Antiviral Portfolio, Establishing Leadership in Treatment of Long COVID and Infection-Associated Chronic Illnesses https://ml.globenewswire.com/media/c6e61521-f249-47fc-ba7e-29e8c1ed809f/small/untitled-design-png.png https://iraqhealthcarewire.com/article/907567815-orchestra-biomed-to-present-avim-therapy-clinical-and-mechanistic-data-at-hrs-2026 Iraq Healthcare Wire en PressRelease 2026-04-23T16:00:00+00:00 Orchestra BioMed to Present AVIM Therapy Clinical and Mechanistic Data at HRS 2026 https://ml.globenewswire.com/media/00697d05-bd34-4570-822b-f204caf21694/small/ogsk2sgeyptxenjnnf5a-png.png https://iraqhealthcarewire.com/article/907568034-catheter-precision-to-attend-and-share-new-clinical-data-at-the-47th-annual-heart-rhythm-society-meeting Iraq Healthcare Wire en PressRelease 2026-04-23T16:00:00+00:00 Catheter Precision to Attend and Share New Clinical Data at the 47th Annual Heart Rhythm Society Meeting https://ml.globenewswire.com/media/cb9f10dc-be78-4c7c-a235-81bfdd77f03c/small/catheterlogo-jpg.jpg https://iraqhealthcarewire.com/article/907566642-chiffre-d-affaires-du-1er-trimestre-2026 Iraq Healthcare Wire en PressRelease 2026-04-23T15:45:00+00:00 Chiffre d’affaires du 1er trimestre 2026 https://ml-eu.globenewswire.com/media/c4731c25-21f2-47d1-910e-edbaeb4de604/small/ https://iraqhealthcarewire.com/article/907566874-q1-2026-revenue Iraq Healthcare Wire en PressRelease 2026-04-23T15:45:00+00:00 Q1 2026 revenue https://ml-eu.globenewswire.com/media/c4731c25-21f2-47d1-910e-edbaeb4de604/small/logo-color-cmjn-bd-jpg.jpg https://iraqhealthcarewire.com/article/907549633-fsr-in-partnership-with-ats-welcomes-dr-matt-craig-to-drive-strategic-research-initiatives Iraq Healthcare Wire en PressRelease 2026-04-23T14:35:37+00:00 FSR, in Partnership with ATS, Welcomes Dr. Matt Craig to Drive Strategic Research Initiatives https://ml.globenewswire.com/media/cb9862de-da73-457c-922e-18812ff4e604/medium/j-matt-craig-phd-joins-fsr-and-ats.png https://iraqhealthcarewire.com/article/907546299-new-data-quantifies-the-nasm-premium-certified-professionals-earn-22-more-than-industry-peers Iraq Healthcare Wire en PressRelease 2026-04-23T14:34:00+00:00 New Data Quantifies the "NASM Premium": Certified Professionals Earn 22% More Than Industry Peers https://ml.globenewswire.com/media/ZDk4NDBjYzYtNmUyOC00ZTQ1LTk2ZjgtNzY0OWVlMWRmM2YxLTEyNjU1NTctMjAyNi0wNC0yMy1lbg==/tiny/The-National-Academy-of-Sports.png https://iraqhealthcarewire.com/article/907549599-mother-s-day-gift-ideas-for-moms-experiential-gifts-like-cooking-together-trending-in-2026 Iraq Healthcare Wire en PressRelease 2026-04-23T14:26:07+00:00 Mother’s Day Gift Ideas for Moms: Experiential Gifts Like Cooking Together Trending in 2026 https://ml.globenewswire.com/media/N2IwYmVlZjktN2JjOC00Njk5LWIxZmEtMzJhMGQwZWZjYzVlLTEzMjI2OTEtMjAyNi0wNC0yMy1lbg==/tiny/Raddish-Kids-Inc-.png https://iraqhealthcarewire.com/article/907546830-the-center-for-cancer-and-blood-disorders-receives-authorization-to-administer-fda-approved-car-t-cell-therapy-begins-treating-first-community Iraq Healthcare Wire en PressRelease 2026-04-23T14:05:00+00:00 The Center for Cancer and Blood Disorders receives authorization to administer FDA-approved CAR T-cell therapy; begins treating first community oncology patient in Maryland-area clinic https://ml.globenewswire.com/media/bb25f585-c65f-49ae-833e-6a3c04e2e01c/medium/the-center-for-cancer-and-blood-disorders-receives-authoriza.png https://iraqhealthcarewire.com/article/907549514-verano-founder-and-chief-executive-officer-george-archos-celebrates-historic-announcement-confirming-cannabis-rescheduling-to-schedule-iii Iraq Healthcare Wire en PressRelease 2026-04-23T13:55:00+00:00 Verano Founder and Chief Executive Officer George Archos Celebrates Historic Announcement Confirming Cannabis Rescheduling to Schedule III https://ml.globenewswire.com/media/18f2c9e0-d960-440b-a51f-b7d7ea7c9e08/small/verano-company-logo-png.png https://iraqhealthcarewire.com/article/907549410-jushi-holdings-inc-applauds-president-trump-and-administration-for-delivering-on-cannabis-rescheduling-to-schedule-iii-under-the-controlled Iraq Healthcare Wire en PressRelease 2026-04-23T13:43:18+00:00 Jushi Holdings Inc. Applauds President Trump and Administration for Delivering on Cannabis Rescheduling to Schedule III under the Controlled Substances Act https://ml.globenewswire.com/media/e65f15fd-322c-4847-83c5-ceafe27f97d5/small/jushi-png.png https://iraqhealthcarewire.com/article/907547420-lumina-therapy-alliance-expands-silicon-valley-presence-with-addition-of-wise-mind-institute-in-redwood-city-ca Iraq Healthcare Wire en PressRelease 2026-04-23T13:40:00+00:00 Lumina Therapy Alliance Expands Silicon Valley Presence with Addition of Wise Mind Institute in Redwood City, CA https://ml.globenewswire.com/media/046b4a15-6585-4d91-936e-8041854f2835/small/lumina-logo-li-1-png.png https://iraqhealthcarewire.com/article/907548326-innocare-releases-2026-q1-results-strong-revenue-growth-and-sustained-profitability Iraq Healthcare Wire en PressRelease 2026-04-23T13:20:49+00:00 InnoCare Releases 2026 Q1 Results: Strong Revenue Growth and Sustained Profitability https://ml.globenewswire.com/media/2dc70b00-a0b0-4d85-adef-2717a7067aec/small/innocare-eng-logo-horizontal-png.png https://iraqhealthcarewire.com/article/907545780-women-are-ditching-generic-diets-for-cycle-based-wellness-this-cycle-diet-app-review-explains-why Iraq Healthcare Wire en PressRelease 2026-04-23T13:15:00+00:00 Women Are Ditching Generic Diets for Cycle-Based Wellness – This Cycle Diet App Review Explains Why https://ml-eu.globenewswire.com/media/70993e65-50d6-4174-b0c0-529713dd084f/medium/cycle-diet-cycle-based-weight-loss-program.png https://iraqhealthcarewire.com/article/907548102-leading-kidney-organizations-unite-on-capitol-hill-for-kidney-diseases-the-hidden-crisis-in-american-health-care-congressional-briefing Iraq Healthcare Wire en PressRelease 2026-04-23T13:14:54+00:00 Leading Kidney Organizations Unite on Capitol Hill for “Kidney Diseases: The Hidden Crisis in American Health Care” Congressional Briefing https://ml.globenewswire.com/media/MjQwZmE4YjctZmI0OS00NTljLThhY2MtMTM5ZmNiNjdiYzYxLTExMDkwNTItMjAyNi0wNC0yMy1lbg==/tiny/American-Kidney-Fund.png https://iraqhealthcarewire.com/article/907538473-alpha-tau-announces-fda-approval-of-ide-supplement-to-expand-alpha-dart-impact-trial-to-patients-with-pancreatic-cancer-receiving-gemcitabine-with Iraq Healthcare Wire en PressRelease 2026-04-23T13:02:00+00:00 Alpha Tau Announces FDA Approval of IDE Supplement to Expand Alpha DaRT® IMPACT Trial to Patients with Pancreatic Cancer Receiving Gemcitabine with Abraxane® (Nab-Paclitaxel) https://ml.globenewswire.com/media/a9de6f03-a487-4934-98e9-d25cdb4c8bed/small/atm-logo-jpg.jpg https://iraqhealthcarewire.com/article/907536253-alpha-tau-successfully-treats-first-pancreatic-cancer-patient-in-europe-with-alpha-dart-in-french-multicenter-acapella-clinical-trial Iraq Healthcare Wire en PressRelease 2026-04-23T13:01:00+00:00 Alpha Tau Successfully Treats First Pancreatic Cancer Patient in Europe with Alpha DaRT® in French Multicenter ACAPELLA Clinical Trial https://ml.globenewswire.com/media/a9de6f03-a487-4934-98e9-d25cdb4c8bed/small/atm-logo-jpg.jpg https://iraqhealthcarewire.com/article/907526664-philips-launches-new-bridge-plus-occlusion-balloon-to-help-manage-rare-but-life-threatening-svc-tears-during-lead-extraction Iraq Healthcare Wire en PressRelease 2026-04-23T13:00:00+00:00 Philips launches new Bridge Plus Occlusion Balloon to help manage rare but life-threatening SVC tears during lead extraction https://ml-eu.globenewswire.com/media/e5826782-01bc-45e7-b448-9ca1eae0125e/small/philips-logo-logotype-emblem-700x128-png.png https://iraqhealthcarewire.com/article/907529427-neura-health-to-expand-access-to-migraine-care-via-lillydirect Iraq Healthcare Wire en PressRelease 2026-04-23T13:00:00+00:00 Neura Health to Expand Access to Migraine Care via LillyDirect https://ml.globenewswire.com/media/306a1f86-8530-49f8-aa6b-3c6364cbcde1/small/neura-logo-png.png https://iraqhealthcarewire.com/article/907531469-neocis-and-yomi-s-named-winner-of-the-2026-tag-awards-for-medtech-in-robotic-procedural-innovation Iraq Healthcare Wire en PressRelease 2026-04-23T13:00:00+00:00 Neocis and Yomi® S Named Winner of the 2026 TAG Awards for MedTech in Robotic & Procedural Innovation https://ml.globenewswire.com/media/b2a5a1e1-cc7c-4d46-8ac3-c0f2a3682be2/small/neocis-alternate-png.png https://iraqhealthcarewire.com/article/907532046-dogwood-therapeutics-announces-worldwide-development-and-commercialization-partnership-for-anti-viral-assets-with-potential-value-up-to-100m Iraq Healthcare Wire en PressRelease 2026-04-23T13:00:00+00:00 Dogwood Therapeutics Announces Worldwide Development and Commercialization Partnership for Anti-Viral Assets with Potential Value up to $100M https://ml.globenewswire.com/media/7fe5cc47-6599-477c-a858-0f0d9b9f7eb5/small/green-and-gray-png.png https://iraqhealthcarewire.com/article/907532364-connect-biopharma-announces-enrollment-in-phase-2-seabreeze-stat-studies-will-continue-as-planned-following-pre-specified-interim-analysis Iraq Healthcare Wire en PressRelease 2026-04-23T13:00:00+00:00 Connect Biopharma Announces Enrollment in Phase 2 Seabreeze STAT Studies Will Continue as Planned Following Pre-Specified Interim Analysis https://ml.globenewswire.com/media/831dcc2a-691d-4cad-813e-855f9fa2bd69/small/connect-logo-cmyk-jpg.jpg https://iraqhealthcarewire.com/article/907532701-maps-celebrates-40-years-at-a-defining-moment-for-psychedelics Iraq Healthcare Wire en PressRelease 2026-04-23T13:00:00+00:00 MAPS Celebrates 40 Years at a Defining Moment for Psychedelics https://ml.globenewswire.com/media/4f774750-4742-4818-be22-116e2b2085b1/small/maps-logo-2021-primary-horizontal-white-background-1200x486.jpg https://iraqhealthcarewire.com/article/907534875-codexis-to-report-first-quarter-2026-financial-results-on-may-7 Iraq Healthcare Wire en PressRelease 2026-04-23T13:00:00+00:00 Codexis to Report First Quarter 2026 Financial Results on May 7 https://ml.globenewswire.com/media/ebbfa755-c2db-4783-aace-43c700ba3369/small/codexis-logo-september-2023-png.png https://iraqhealthcarewire.com/article/907538601-h1-launches-site-network-suite-the-first-ai-powered-platform-to-transform-how-research-sites-and-sponsors-engage-on-clinical-trials Iraq Healthcare Wire en PressRelease 2026-04-23T13:00:00+00:00 H1 Launches Site Network Suite, the First AI-Powered Platform to Transform How Research Sites and Sponsors Engage on Clinical Trials https://ml.globenewswire.com/media/dc362fcf-5008-429c-bf37-cf26402cd802/small/h1-logo-primary-4x-21-png.png https://iraqhealthcarewire.com/article/907538664-heald-partners-with-thatch-marketplace-to-bring-first-of-its-kind-diabetes-reversal-program-to-employees Iraq Healthcare Wire en PressRelease 2026-04-23T13:00:00+00:00 Heald Partners with Thatch Marketplace to Bring First-of-its-Kind Diabetes Reversal Program to Employees https://ml.globenewswire.com/media/5ed5f22c-5871-49c8-b232-ab058a530369/small/heald-logo-2-png.png https://iraqhealthcarewire.com/article/907538714-tilray-brands-positioned-for-u-s-expansion-amid-historic-cannabis-rescheduling Iraq Healthcare Wire en PressRelease 2026-04-23T12:53:52+00:00 Tilray Brands Positioned for U.S. Expansion Amid Historic Cannabis Rescheduling https://ml.globenewswire.com/media/2dbf85bb-5e30-4623-8f9b-931442240c05/small/tilraybrands-logo-fullcolor-rbg-horiz-01-png.png https://iraqhealthcarewire.com/article/907530858-ritedose-university-of-south-carolina-welcome-top-european-business-students-for-immersive-learning-about-advanced-manufacturing Iraq Healthcare Wire en PressRelease 2026-04-23T12:37:00+00:00 Ritedose, University of South Carolina Welcome Top European Business Students for Immersive Learning about Advanced Manufacturing https://ml.globenewswire.com/media/7d397bb5-f152-4003-abe7-88a69feaf034/medium/ritedose-university-in-action.jpg https://iraqhealthcarewire.com/article/907527341-vericel-to-report-first-quarter-2026-financial-results-on-may-7-2026 Iraq Healthcare Wire en PressRelease 2026-04-23T12:30:00+00:00 Vericel to Report First-Quarter 2026 Financial Results on May 7, 2026 https://ml.globenewswire.com/media/6a144258-8523-493f-8a1e-ccceec233208/small/vericel-corporation-logo.jpg https://iraqhealthcarewire.com/article/907527777-icu-medical-announces-time-of-first-quarter-2026-earnings-conference-call Iraq Healthcare Wire en PressRelease 2026-04-23T12:30:00+00:00 ICU Medical Announces Time of First Quarter 2026 Earnings Conference Call https://ml.globenewswire.com/media/44f52bc4-1355-405c-bdac-609254095f19/small/icu-medical-logo-jpg.jpg https://iraqhealthcarewire.com/article/907530786-cytodyn-to-host-investor-webcast Iraq Healthcare Wire en PressRelease 2026-04-23T12:30:00+00:00 CytoDyn to Host Investor Webcast https://ml.globenewswire.com/media/3b426b4d-6299-4c23-9f95-058174a5b7be/small/new-logo-png.png https://iraqhealthcarewire.com/article/907531167-renovorx-announces-pharmacokinetic-and-pharmacodynamic-data-abstract-supporting-the-tamp-therapy-platform-accepted-for-presentation-at-the-2026-asco Iraq Healthcare Wire en PressRelease 2026-04-23T12:30:00+00:00 RenovoRx Announces Pharmacokinetic and Pharmacodynamic Data Abstract Supporting the TAMP™ Therapy Platform Accepted for Presentation at the 2026 ASCO Annual Meeting https://ml.globenewswire.com/media/e18bf823-ff44-4bbd-82b9-3a311d58dad8/small/final-logo-horizontal-png.png https://iraqhealthcarewire.com/article/907531450-ss-innovations-unveils-cutting-edge-surgical-robotic-technologies-at-smrsc-2026 Iraq Healthcare Wire en PressRelease 2026-04-23T12:30:00+00:00 SS Innovations Unveils Cutting-Edge Surgical Robotic Technologies at SMRSC 2026 https://ml.globenewswire.com/media/5ab9180b-915c-4e02-838c-f5a9e458e61d/medium/ssi-vimana-aero-drone-system.png https://iraqhealthcarewire.com/article/907531754-enlivex-to-present-phase-iia-3-month-and-6-month-data-of-allocetra-at-oarsi-2026-world-congress Iraq Healthcare Wire en PressRelease 2026-04-23T12:30:00+00:00 Enlivex to Present Phase IIa 3-month and 6-month Data of Allocetra at OARSI 2026 World Congress https://ml.globenewswire.com/media/27d4e006-8709-4fd1-8341-5b58381487d4/small/picture1-jpg.jpg https://iraqhealthcarewire.com/article/907531972-polaryx-therapeutics-to-participate-in-national-tay-sachs-allied-diseases-association-annual-family-conference Iraq Healthcare Wire en PressRelease 2026-04-23T12:30:00+00:00 Polaryx Therapeutics to Participate in National Tay-Sachs & Allied Diseases Association Annual Family Conference https://ml.globenewswire.com/media/64e2f507-40e8-46aa-b22e-6661e7035467/small/polaryx-logonew-png.png https://iraqhealthcarewire.com/article/907535034-oncotelic-therapeutics-inc-otcqb-otlc-real-world-example-of-scientific-advancement-influence-on-evaluation Iraq Healthcare Wire en PressRelease 2026-04-23T12:30:00+00:00 Oncotelic Therapeutics Inc. (OTCQB: OTLC) Real-World Example of Scientific Advancement Influence on Evaluation https://ml.globenewswire.com/media/aa650511-a1c3-496e-803a-448d7f8d409a/small/picture1-jpg.jpg